NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled
NCT02817633 2025-10-28A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)Tesaro, Inc.Phase 1 Active not recruiting463 enrolled